Interventional Cardiology - Latest articles

Show: Order by: Page size:

Results 1 to 30 of 111:

Prof. MUDr. Michael Aschermann, DrSc., FESC, FAAC, osmdesátiletýLaudatio

doc. MUDr. František Holm, CSc.

Interv Akut Kardiol. 2024;23(2-3):142-143  

Prim. MUDr. Ladislav Groch, Ph.D., sedmdesátiletýLaudatio

MUDr. Ota Hlinomaz, CSc.

Interv Akut Kardiol. 2024;23(2-3):140-141  

MUDr. Tomáš Janota, CSc., slaví šedesáté páté narozeninyLaudatio

Michal Vrablík

Interv Akut Kardiol. 2024;23(2-3):139  

CASTLE-HTxHot-line

Štěpán Havránek

Interv Akut Kardiol. 2024;23(2-3):136-138 | DOI: 10.36290/kar.2024.015  

The CASTLE HTx trial showed a significant reduction in the primary composite endpoint in patients with advanced heart failure with reduced ejection fraction and atrial fibrillation who were treated with catheter ablation in addition to optimal medical treatment of heart failure. Catheter ablation was compared with optimal medical treatment alone. The primary endpoint was a composite of death from any cause, implantation of a left ventricular assist device, and urgent heart transplantation.

Randomized comparison of concomitant surgical treatment of persistent atrial fibrillation and hybrid approach -data from national multicentric SURHYB trialHot-line

Alan Bulava, Dan Wichterle, Aleš Mokráček, Pavel Osmančík, Petr Budera, Petr Kačer, Linda Vetešková, Petr Němec, Tomáš Skála, Petr Šantavý, Jan Chovančík, Piotr Branny, Vitalii Rizov, Miroslav Kolesár, Iva Šafaříková, Marian Rybář

Interv Akut Kardiol. 2024;23(2-3):127-135  

Aims: To assess whether the timely pre-emptive radiofrequency (RF) catheter ablation would achieve higher freedom from atrial fibrillation (AF) or atrial tachycardia (AT) and be associated with better clinical outcomes than surgical ablation (CryoMaze) alone in patients with structural heart disease indicated for concomitant AF treatment. Methods: The trial investigated patients with non-paroxysmal AF undergoing coronary artery bypass grafting and/or valve repair/replacement with mandatory concomitant CryoMaze procedure who were randomly assigned to undergo either RF catheter ablation three months post CryoMaze (Hybrid Group) or no further treatment...

The effect of nurse-led intervention on the quality of life of patients with stable coronary artery diseaseNon-medical professions

Petra Bejvančická, Helena Rojíková Svobodová, Pavlína Tůmová, Sylva Bártlová, Iva Brabcová, Lenka Šedová

Interv Akut Kardiol. 2024;23(2-3):119-126 | DOI: 10.36290/kar.2024.021  

Aim: To find and describe nurse-coordinated interventions and their effect on quality of life scores of patients with stable coronary artery disease (CAD), including a description of the conceptual framework of the intervention and the most important aspects of the nursing care provided.  Methodology: A review study. PubMed, Scopus, Web of Science, ProQuest, Google Scholar databases were studied. To determine the basic components, a clinical question was asked using the acronym PICO (Patient/Problem, Intervention, Comparison and Outcome). The population consisted of patients with stable CAD (P), the nurse-coordinated education/intervention...

Biomedical engineering in contemporary Czech cardiologyAn insight into biomedical engineering

David Pospíšil, Monika Míková, Jan Řehoř, Kristýna Hochmanová, Veronika Bulková, Nela Hejtmánková

Interv Akut Kardiol. 2024;23(2-3):110-118 | DOI: 10.36290/kar.2024.023  

Biomedical engineering has become an integral part of modern cardiac care, opening up new possibilities for the diagnosis and treatment of heart disease. This interdisciplinary field combines technical and medical expertise to create innovative solutions that improve the quality of life for patients. Within cardiology, biomedical engineers are most commonly employed in fields such as electrophysiology, non-invasive cardiology, interventional cardiology, telemedicine and other specialised fields where, in addition to clinical work, they use their expertise to optimise technologies and medical devices. They are also involved in the development and improvement...

EuroVASC - European Vascular Club and its creation in 2024Information

Ivo Bernat

Interv Akut Kardiol. 2024;23(2-3):108-109 | DOI: 10.36290/kar.2024.016  

The article informs about the establishment of the EuroVASC and its planned activities.

Using Impella CP mechanical heart support in a patient with TAVI EvolutCase reports

Štěpán Jirouš, David Horák, David Slezák, Jan Lhotský, Vít Buriánek, Štefan Volovár, Ivo Bernat, Richard Rokyta

Interv Akut Kardiol. 2024;23(2-3):103-107 | DOI: 10.36290/kar.2024.014  

We present the rare possibility of using the mechanical heart support Impella CP Smart Assist (Abiomed) introduced through the biological aortic replacement Evolut (Medtronic). Among the absolute contraindications for the introduction of Impella is the presence of a mechanical aortic valve prosthesis but not that of a bioprosthesis in the aortic position. However, the US FDA warns against the introduction of Impella through the Evolut bioprosthesis due to the risk of interactions between the in-flow and out-flow of the Impella and the edge of the stent, with the possibility of damage to the pump function. Nevertheless, the insertion of this support...

A beta blocker and ACE inhibitor combination in treating hypertension and its complicationsReview articles

Ondřej Petrák

Interv Akut Kardiol. 2024;23(2-3):96-102 | DOI: 10.36290/kar.2024.013  

Arterial hypertension is one of the controllable risk factors for atherosclerosis, and early medical intervention significantly reduces cardiovascular morbidity and mortality. The treatment should be tailored to the given patient according to the severity of hypertension and cardiovascular and metabolic risk profile. The trend in current therapy is to use fixed combinations to achieve blood pressure target values more rapidly with fewer side effects and to improve adherence to treatment. The combination of a beta blocker (bisoprolol) and an ACE inhibitor (perindopril) has complementary effects on the sympathetic nervous system and the renin-angiotensin-aldosterone...

Chirurgická léčba pseudoaneuryzmatu hrudní aorty: systematický přehled literaturyReview articles

Sandra Rečičárová, Kateřina Lawrie, Michael Jonák, Ivan Netuka

Interv Akut Kardiol. 2024;23(2-3):90-95 | DOI: 10.36290/kar.2024.012  

Introduction: Thoracic aortic false aneurysm is a rare complication of cardiac surgery or procedures on the thoracic aorta. We present the results of a systematic review of the literature. Our aim was to determine the best treatment options and surgical techniques. Methods: We performed a literature search regarding thoracic aortic pseudoaneurysm and its surgical treatment in English, limited by the dates 1st January 1979 to 31st December 2022. We searched the PubMed and EMBASE databases for the following medical terms: thoracic aortic false aneurysm, pseudoaneurysm, and surgical treatment.  Results: Our search screened 4,046 articles....

Out-of-Hospital Cardiac Arrest in the Karlovy Vary Region in 2023: An Utstein-Style ReportOriginal articles

Viktorie Šimečková, Lýdie Klempová, Pavel Provazník, Václav Budín, Iveta Šejbová, Adam Gabriel, Michal Klapuch, Gustav Sosnovec, Jiří Smetana, Roman Sýkora, David Peřan

Interv Akut Kardiol. 2024;23(2-3):85-89 | DOI: 10.36290/kar.2024.022  

Introduction: The Emergency Medical Services (EMS) of the Karlovy Vary Region, serving over 295,000 residents, faces the critical challenge of managing out-of-hospital cardiac arrests (OHCA). Effective cardiopulmonary resuscitation (CPR) is essential for survival, requiring coordinated efforts from dispatch to first responders. This article analyses the quality of CPR in 2023 using the Utstein protocol, following an internal audit that introduced a feedback system to enhance outcomes. Methods: This study retrospectively examines the 2023 Cardiac Arrest Registry of the Karlovy Vary Region using the 2024 Utstein template. Data were analysed with...

Surgical treatment of acute pulmonary embolismMain topic

Miroslav Kolárik, Petr Fila, Petr Němec

Interv Akut Kardiol. 2024;23(2-3):81-84 | DOI: 10.36290/kar.2024.024  

Acute pulmonary embolism is still marked with a relatively high mortality burden. In the era of modern medicine, several approaches have been developed. Surgical treatment, in the light of current guidelines, is reserved for the highest-risk patients with hemodynamic instability. Surgical procedures and results along with the use of mechanical circulatory support results have been discussed in this text.

Strategy of anticoagulation therapy in outpatients with acute pulmonary embolismMain topic

Petra Vysočanová

Interv Akut Kardiol. 2024;23(2-3):75-80 | DOI: 10.36290/kar.2024.019  

Pulmonary embolism (PE) is the most feared clinical presentation of venous thromboembolism (VTE). Outpatient physicians encounter patients with PE who have either been recently discharged from hospital or are treated for PE on an outpatient basis, i.e., completely without hospitalisation or are discharged within the first 24 to 48 hours. Outpatient treatment of pulmonary embolism (PE) is feasible according to expert recommendations and supported by data from clinical trials showing good safety and efficacy of this procedure. For the correct selection of patients with a low risk of complications of PE, not only their stratification to determine the...

Echocardiography in pulmonary embolismMain topic

Marián Felšöci

Interv Akut Kardiol. 2024;23(2-3):69-74 | DOI: 10.36290/kar.2024.018  

Echocardiography is considered as important and frequent imaging method in the diagnostics of pulmonary embolism (PE). In fact, when compared to angiography or nuclear scanning, it does not detect a direct site of the occlusion of the pulmonary arteries but visualizes hemodynamical consequences of the obstruction on the right heart. Echocardiography has a key role in the management of patients with severe forms of PE and in some cases, its crucial for the decision making when reperfusion therapy is considered or when increased monitoring of the patients at intensive care unit is required. Also, it allows to detect other potential causes of the symptoms...

Pulmonary embolism: prophylaxis, diagnosis, acute therapyMain topic

Martin Radvan, Martin Kameník

Interv Akut Kardiol. 2024;23(2-3):64-68 | DOI: 10.36290/kar.2024.020  

Pulmonary embolism is the third most common cardiovascular reason for death after myocardial infarction and stroke. The principles of thromboembolic disease prophylaxis are an integral part of care in both surgical and internal medicine. The severity of pulmonary embolism ranges across the spectrum, from completely asymptomatic forms to obstructive shock, where the first and only symptom is sudden death. The mainstay of treatment for low- and intermediate-risk patients is anticoagulation therapy. For high-risk patients, effective thrombolytic therapy is available, but it has a number of contraindications and, even if these are respected, carries a...

Many faces of betablockersEditors’ foreword

Jan F. Vojáček

Interv Akut Kardiol. 2024;23(2-3):61-63  

Profesor Alain Cribier zemřel dne 16. února 2024 ve věku 79 letObituary

prof. MUDr. Jan F. Vojáček, DrSc.

Interv Akut Kardiol. 2024;23(1):53-54  

Vzpomínka na pana profesora MUDr. Ivana Vaňka, DrSc.Obituary

Jan František Vojáček

Interv Akut Kardiol. 2024;23(1):51-52  

Zemřel pan profesor MUDr. Ivan Vaněk, DrSc.Obituary

prof. MUDr. Jaroslav Lindner, CSc., FICS

Interv Akut Kardiol. 2024;23(1):50  

Proč téma akutní a emergentní echokardiografie?Editors’ foreword

MUDr. Tomáš Janota, CSc., editor hlavního tématu

Interv Akut Kardiol. 2024;23(1):7  

The role of intracoronary thrombolysis in thrombus-laden coronary artery: a case reportCase reports

I Gde Rurus Suryawan, Rizal Muhammad, Fita Triastuti

Interv Akut Kardiol. 2024;23(1):43-49 | DOI: 10.36290/kar.2024.002  

Introduction: Large intracoronary thrombus in patients presenting with ST elevation myocardial infarction (STEMI) can cause distal embolization, the no-reflow phenomenon, and stent thrombosis. Approximately 10% of patients undergoing primary percutaneous coronary intervention (PCI) have distal embolization of thrombus, causing coronary microvascular obstruction and reduced myocardial tissue perfusion. This can lead to ongoing ischemia, a larger infarct size, and a significant increase in 30-day mortality, regardless of successful PCI with normal epicardial vessel flow. Case Presentation: A 51-year-old Asian male presented with STEMI. Coronary angiography...

Hemorrhagic pericardial effusion after removal of the pericardial drain in a penetrating atherosclerotic ulcer of the ascending aorta with pseudoaneurysmCase reports

Silvia Farkašová Iannaccone, Tibor Porubän, Alžbeta Ginelliová, Dorota Sopková, Peter Bohuš, Daniel Farkaš

Interv Akut Kardiol. 2024;23(1):38-42 | DOI: 10.36290/kar.2024.003  

A penetrating atherosclerotic ulcer (PAU) is a type of ulcerative lesion that breaches the internal elastic lamina, allowing for the formation of a hematoma within the medial wall of the aorta (1). PAUs typically occur in advanced atherosclerotic lesions and are more commonly observed in elderly individuals with a higher cardiovascular risk. The clinical course of PAUs can vary and may involve complications such as intramural hematomas, dissection, and pseudoaneurysms (PSA) (2). If the ulcerative lesion extends through the adventitia, it can lead to a life-threatening bleeding, necessitating careful management of PAUs. We report the case of a 66-year-old...

Pharmacological stress test using regadenoson in conventional and dynamic cardiac SPECTCase reports

Milan Kamínek, Vladimír Kincl, Martin Havel

Interv Akut Kardiol. 2024;23(1):33-36 | DOI: 10.36290/kar.2024.001  

Regadenoson as a selective A2A adenosine enables pharmacological stress when exercise stress techniques would be impossible or very difficult. We present two case reports demonstrating its advantages. In case 1, we initially attempted to induce stress using physical exercise in a 77-year-old male patient after coronary artery bypass graft. Due to inadequate heart rate increase, the stress was promptly converted to pharmacological stress using regadenoson in combination with a low level of exercise. Single-photon emission computed tomography (SPECT) showed extensive ischaemia of the lateral wall. Coronary angiography subsequently revealed...

Acute vascular ultrasoundMain topic

Zdislava Štulcová

Interv Akut Kardiol. 2024;23(1):30-32 | DOI: 10.36290/kar.2024.008  

At present, the ultrasound examination is an unreplaceable method, which, thanks to the possibility of examination at the patient's bedside, is used more and more often in acute situations. From the point of view of examination in the acute state, the most important diagnoses are deep vein thrombosis, acute arterial occlusion and post-puncture complications after invasive procedures. The basic indications and basic methodology of these examinations are outlined in this article.

Echocardiographic examination of pericardial effusion and cardiac tamponadeMain topic

Anna Valeriánová, Tomáš Janota

Interv Akut Kardiol. 2024;23(1):24-26 | DOI: 10.36290/kar.2024.007  

Echocardiography is the most accessible, yet very sensitive and reliable method to detect an increased amount of pericardial fluid and to recognize emergent situations requiring pericardial punction and to guide this invasive procedure. The biggest advantages of echocardiography are its' availability bedside and unlimited possibility of repeating the examination. Every doctor working in intensive care should be able to perform a basic ultrasound examination for diagnosing presence of the pericardial effusion and to evaluate its' hemodynamic significance.

Echocardiographic examination in suspected acute pulmonary embolismMain topic

Anna Valeriánová, Tomáš Janota

Interv Akut Kardiol. 2024;23(1):21-23 | DOI: 10.36290/kar.2024.010  

Echocardiography is one of the basic methods in suspected acute pulmonary embolism. In addition to the differential diagnosis of other cardiovascular diseases with similar clinical manifestations to pulmonary embolism, it allows, above all, non-invasive risk stratification of the patient and thus contributes to the decision-making process regarding the treatment strategy. The investigation should should be performed as early as possible at the patient's bedside.

Emergency echocardiography in patients with acute heart failureMain topic

Robert Holaj

Interv Akut Kardiol. 2024;23(1):17-20 | DOI: 10.36290/kar.2024.005  

Transthoracic echocardiography (TTE) is the method of choice for assessment of myocardial systolic and diastolic function of both the left and right ventricles. Echocardiography is a term used here to refer to all cardiac ultrasound imaging techniques, including two-dimensional/three-dimensional echocardiography, pulsed and continuous wave Doppler, colour flow Doppler, tissue Doppler imaging, contrast echocardiography, and deformation imaging (strain and strain rate).

Lung and chest ultrasoundMain topic

Michal Malý

Interv Akut Kardiol. 2024;23(1):14-16 | DOI: 10.36290/kar.2024.009  

Lungs and chest cavities ultrasound has become the standard part of the examinations in intensive care as well as in admission and standard wards. The targeted point-of-care examination is mainly used to rule out chest effusion, and pneumothorax, to assess hyperemia in pulmonary edema or tissue consolidation in pneumonia, and last but not least as a guide to procedures, especially chest punctures and drainages.

Acute echocardiographyMain topic

Tomáš Janota

Interv Akut Kardiol. 2024;23(1):8-13 | DOI: 10.36290/kar.2024.004  

Echocardiography is increasingly used as a rapid examination tool in patients with acute cardiovascular conditions. Such examination is carried out by doctors with various specializations. The article deals with this issue, particularly with the rapid examination of patients with acute chest pain, acute heart failure, shock states, pulmonary embolism, cardiac tamponade, complications of myocardial infarction, acute disease of the ascending aorta as well as other acute cardiovascular conditions and diseases or of those suspected to have them.


Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.